Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma

BACKGROUND: CD276 is an immune checkpoint molecule. Elevated CD276 expression by urothelial carcinoma is associated with poor prognosis, but little is known about its expression across different tumor stages. We therefore investigated CD276 expression in bladder cancer (BC) cells and in tissue sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Aicher, Wilhelm K., Korn, M., Reitnauer, L., Maurer, F. B., Hennenlotter, J., Black, P. C., Todenhofer, T., Bedke, J., Stenzl, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042686/
https://www.ncbi.nlm.nih.gov/pubmed/33845814
http://dx.doi.org/10.1186/s12894-021-00829-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042686/
https://www.ncbi.nlm.nih.gov/pubmed/33845814
http://dx.doi.org/10.1186/s12894-021-00829-0

Ejemplares similares